Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy
Authors
Keywords
-
Journal
Frontiers in Cellular and Infection Microbiology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-10-14
DOI
10.3389/fcimb.2021.710945
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants
- (2021) Anders B. Dohlman et al. Cell Host & Microbe
- In Vivo Transcriptome of Lactobacillus acidophilus and Colonization Impact on Murine Host Intestinal Gene Expression
- (2021) Yong Jun Goh et al. mBio
- Lactobacillus Kefiri LKF01 (Kefibios®) for Prevention of Diarrhoea in Cancer Patients Treated with Chemotherapy: A Prospective Study
- (2021) Michele Ghidini et al. Nutrients
- Modulation of the immune response and metabolism in germ-free rats colonized by the probiotic Lactobacillus salivarius LI01
- (2021) Jiafeng Xia et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Role of Gut Microbiome in the Outcome of Cancer Immunotherapy
- (2021) Junting Ma et al. INTERNATIONAL JOURNAL OF CANCER
- Relationship Between the Gut Microbiome and Systemic Chemotherapy
- (2020) Samantha M. Ervin et al. DIGESTIVE DISEASES AND SCIENCES
- The metabolic effect of gut microbiota on drugs
- (2020) Yuan Xie et al. DRUG METABOLISM REVIEWS
- Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors
- (2020) Matthew H. Taylor et al. JOURNAL OF CLINICAL ONCOLOGY
- Isolation and Structural Characterization of Specific Bacterial β-Glucuronidase Inhibitors from Noni (Morinda citrifolia) Fruits
- (2020) Fei Yang et al. JOURNAL OF NATURAL PRODUCTS
- Early-onset colorectal cancer: initial clues and current views
- (2020) Lorne J. Hofseth et al. Nature Reviews Gastroenterology & Hepatology
- Crypt residing bacteria and proximal colonic carcinogenesis in a mouse model of Lynch syndrome
- (2020) Michaela Lang et al. INTERNATIONAL JOURNAL OF CANCER
- Dietary modifications for enhanced cancer therapy
- (2020) Naama Kanarek et al. NATURE
- Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy
- (2020) Aadra P. Bhatt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome
- (2020) Paulina Markowiak-Kopeć et al. Nutrients
- Ancient Chinese Medicine Herbal Formula Huanglian Jiedu Decoction as a Neoadjuvant Treatment of Chemotherapy by Improving Diarrhea and Tumor Response
- (2020) Yau-Tuen Chan et al. Frontiers in Pharmacology
- Dihydrotanshinone attenuates chemotherapy-induced intestinal mucositis and alters fecal microbiota in mice
- (2020) Lin Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview
- (2020) Mateusz Kciuk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Does a ketogenic diet as an adjuvant therapy for drug treatment enhance chemotherapy sensitivity and reduce target lesions in patients with locally recurrent or metastatic Her-2-negative breast cancer? Study protocol for a randomized controlled trial
- (2020) Yan Wang et al. Trials
- Antibiotics Improve the Treatment Efficacy of Oxaliplatin-Based but Not Irinotecan-Based Therapy in Advanced Colorectal Cancer Patients
- (2020) Hiroo Imai et al. Journal of Oncology
- The impact of modulating the gastrointestinal microbiota in cancer patients
- (2020) Egidijus Morkūnas et al. Best Practice & Research Clinical Gastroenterology
- The introduction of immunosuppressor (TDO inhibitor) significantly improved the efficacy of irinotecan in treating hepatocellular carcinoma
- (2020) Qingqing Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cryptotanshinone alleviates chemotherapy-induced colitis in mice with colon cancer via regulating fecal-bacteria-related lipid metabolism
- (2020) Lin Wang et al. PHARMACOLOGICAL RESEARCH
- The synergistic anticancer effects of ReoT3D, CPT-11, and BBI608 on murine colorectal cancer cells
- (2020) Abouzar Babaei et al. DARU-Journal of Pharmaceutical Sciences
- Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening
- (2020) Thomas Hueso et al. Gut Microbes
- Prevention of Clostridium difficile Infection and Associated Diarrhea: An Unsolved Problem
- (2020) Nicola Principi et al. Microorganisms
- Effects of dietary fibre intake in chemotherapy-induced mucositis in murine model
- (2020) B. Gallotti et al. BRITISH JOURNAL OF NUTRITION
- Effects of Protein and Calorie Restriction on the Metabolism and Toxicity Profile of Irinotecan in Cancer Patients
- (2020) Femke M. Man et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time
- (2020) Emma C. Hulshof et al. EUROPEAN JOURNAL OF CANCER
- Enhancing anti-tumour efficacy with immunotherapy combinations
- (2020) Funda Meric-Bernstam et al. LANCET
- The gut microbiota is associated with immune cell dynamics in humans
- (2020) Jonas Schluter et al. NATURE
- Targeting gut microbiota with dietary components on cancer: Effects and potential mechanisms of action
- (2019) Jun Tao et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy
- (2019) Seiji Mabuchi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity
- (2019) Ali N. Chamseddine et al. PHARMACOLOGY & THERAPEUTICS
- The Gut Microbiota in Causation, Detection, and Treatment of Cancer
- (2019) Clodagh L. Murphy et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Efficacy and Safety of Xiao Ai Ping Injection Combined with Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis
- (2019) Kerui Wu et al. Evidence-based Complementary and Alternative Medicine
- Preventative effects of selenium-enriched Bifidobacterium longum on irinotecan-induced small intestinal mucositis in mice
- (2019) Y. Qiu et al. Beneficial Microbes
- Mapping human microbiome drug metabolism by gut bacteria and their genes
- (2019) Michael Zimmermann et al. NATURE
- Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
- (2019) Shinichi Yachida et al. NATURE MEDICINE
- The clinical application of fruquintinib on colorectal cancer
- (2019) Zhongguang Chen et al. Expert Review of Clinical Pharmacology
- Phage-guided modulation of the gut microbiota of mouse models of colorectal cancer augments their responses to chemotherapy
- (2019) Di-Wei Zheng et al. Nature Biomedical Engineering
- A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model
- (2019) Jinhee Kim et al. BIOMEDICINE & PHARMACOTHERAPY
- The administration of Escherichia coli Nissle 1917 ameliorates irinotecan–induced intestinal barrier dysfunction and gut microbial dysbiosis in mice
- (2019) Yurong Wang et al. LIFE SCIENCES
- Adjuvant chemotherapy in resected colon cancer: When, how and how long?
- (2019) Alain J. Gelibter et al. SURGICAL ONCOLOGY-OXFORD
- Mouse Gut Microbiome-Encoded β-Glucuronidases Identified Using Metagenome Analysis Guided by Protein Structure
- (2019) Benjamin C. Creekmore et al. mSystems
- Pembrolizumab in Combination with the Oncolytic Virus Pelareorep and Chemotherapy in Patients with Advanced Pancreatic Adenocarcinoma: A Phase Ib Study
- (2019) Devalingam Mahalingam et al. CLINICAL CANCER RESEARCH
- Irinotecan: 25 years of cancer treatment
- (2019) Christian Bailly PHARMACOLOGICAL RESEARCH
- Search and Selection of Probiotics That Improve Mucositis Symptoms in Oncologic Patients. A Systematic Review
- (2019) José Antonio Picó-Monllor et al. Nutrients
- Synergistic Anti-Tumor Effect of mTOR Inhibitors with Irinotecan on Colon Cancer Cells
- (2019) Damien Reita et al. Cancers
- Discovering the Microbial Enzymes Driving Drug Toxicity with Activity-Based Protein Profiling
- (2019) Parth B. Jariwala et al. ACS Chemical Biology
- Identify old drugs as selective bacterial β‐GUS inhibitors by structural‐based virtual screening and bio‐evaluations
- (2019) Zhou Chen et al. Chemical Biology & Drug Design
- The study of inhibitory effect of natural flavonoids toward β-glucuronidase and interaction of flavonoids with β-glucuronidase
- (2019) Cheng-Peng Sun et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Multi-institutional retrospective analysis of FOLFIRI in patients with advanced biliary tract cancers
- (2019) Jonathan D Mizrahi et al. World Journal of Gastrointestinal Oncology
- Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
- (2018) Danielle C. Glassman et al. BMC CANCER
- Relevance of CYP3A4*20 , UGT1A1*37 and UGT1A1*28 variants in irinotecan-induced severe toxicity
- (2018) Pau Riera et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
- (2018) Femke M. de Man et al. CLINICAL PHARMACOKINETICS
- Anti-proliferative, pro-apoptotic and anti-oxidative activity of Lactobacillus and Bifidobacterium strains: A review of mechanisms and therapeutic perspectives
- (2018) Adriana Nowak et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Potential pharmacokinetic herb-drug interactions: have we overlooked the importance of human carboxylesterases 1 and 2?
- (2018) Jing Xu et al. CURRENT DRUG METABOLISM
- Current updates in management of Clostridium difficile infection in cancer patients
- (2018) Muhammad Aziz et al. CURRENT MEDICAL RESEARCH AND OPINION
- Butyrate, a dietary fiber derivative that improves irinotecan effect in colon cancer cells
- (2018) João Crispim Encarnação et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Efecto de los polimorfismos en UGT , SLCO , ABCB y ABCC en la toxicidad del tratamiento con irinotecán
- (2018) Sara García Gil et al. MEDICINA CLINICA
- Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer
- (2018) Patrice D. Cani et al. Nature Reviews Gastroenterology & Hepatology
- Exopolysaccharides produced by Lactobacillus strains suppress HT‑29 cell growth via induction of G0/G1 cell cycle arrest and apoptosis
- (2018) Wei Di et al. Oncology Letters
- Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer
- (2018) Hongyang Lu et al. INTEGRATIVE CANCER THERAPIES
- Effect of Hangeshashin-To (Japanese Herbal Medicine Tj-14) on Tolerability of Irinotecan: Propensity Score and Instrumental Variable Analyses
- (2018) Hirokazu Urushiyama et al. Journal of Clinical Medicine
- 1682O_PRFinal results of a phase II/III, randomized, double blind, placebo-controlled study to investigate the efficacy of a high potency multistrain probiotic, on chemotherapy induced diarrhea in cancer patients receiving fluropyrimidines and/or irinotecan-based therapy
- (2018) A Sharma et al. ANNALS OF ONCOLOGY
- Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice
- (2018) Yihan Wu et al. BIOMEDICINE & PHARMACOTHERAPY
- An insight into gut microbiota and its functionalities
- (2018) Atanu Adak et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Xiao-Chai-Hu-Tang (XCHT) intervening irinotecan's disposition: The potential of XCHT in alleviating irinotecan-induced diarrhea
- (2018) Rongjin Sun et al. CURRENT CANCER DRUG TARGETS
- Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients
- (2018) Hamzah Abu-Sbeih et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo
- (2018) Kai-Wen Cheng et al. PHARMACOLOGICAL RESEARCH
- Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine
- (2018) Adam Paulík et al. TUMORI
- Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial
- (2017) Rajen Mody et al. LANCET ONCOLOGY
- Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria
- (2017) Jean Guy LeBlanc et al. Microbial Cell Factories
- Gut microbiota modulation of chemotherapy efficacy and toxicity
- (2017) James L. Alexander et al. Nature Reviews Gastroenterology & Hepatology
- Chemical transformation of xenobiotics by the human gut microbiota
- (2017) Nitzan Koppel et al. SCIENCE
- An Atlas of β-Glucuronidases in the Human Intestinal Microbiome
- (2017) Rebecca M. Pollet et al. STRUCTURE
- Exopolysaccharides from Lactobacillus plantarum NCU116 induce c-Jun dependent Fas/Fasl-mediated apoptosis via TLR2 in mouse intestinal epithelial cancer cells
- (2017) Xingtao Zhou et al. Scientific Reports
- Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity
- (2017) Huan-yu Guan et al. Frontiers in Pharmacology
- Oncolytic Viruses in Cancer Treatment
- (2017) Sean E. Lawler et al. JAMA Oncology
- Amoxapine Demonstrates Incomplete Inhibition of β-Glucuronidase Activity from Human Gut Microbiota
- (2017) Wei Yang et al. SLAS Discovery
- Fish oil mitigates myosteatosis and improves chemotherapy efficacy in a preclinical model of colon cancer
- (2017) Alaa A. Almasud et al. PLoS One
- Fasting protects against the side effects of irinotecan treatment but does not affect anti-tumour activity in mice
- (2016) Sander A Huisman et al. BRITISH JOURNAL OF PHARMACOLOGY
- 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study
- (2016) Michael Wallington et al. LANCET ONCOLOGY
- The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
- (2016) Peter Spanogiannopoulos et al. NATURE REVIEWS MICROBIOLOGY
- Irinotecan-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses
- (2016) J M Campbell et al. PHARMACOGENOMICS JOURNAL
- Saccharomyces cerevisiae UFMG A-905 treatment reduces intestinal damage in a murine model of irinotecan-induced mucositis
- (2016) R.W. Bastos et al. Beneficial Microbes
- Irinotecan as a Second-line Chemotherapy for Small Cell Lung Cancer: a Systemic Analysis
- (2015) Ming-Qian Zhang et al. Asian Pacific Journal of Cancer Prevention
- Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity
- (2015) Bret D. Wallace et al. CHEMISTRY & BIOLOGY
- Prevention of irinotecan induced diarrhea by probiotics: A randomized double blind, placebo controlled pilot study
- (2015) Michal Mego et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study
- (2015) Aude Teillant et al. LANCET INFECTIOUS DISEASES
- Evaluation of mucositis induced by irinotecan after microbial colonization in germ-free mice
- (2015) Silvia H. S. P. Pedroso et al. MICROBIOLOGY-SGM
- Fusobacterium nucleatumand T Cells in Colorectal Carcinoma
- (2015) Kosuke Mima et al. JAMA Oncology
- The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018)
- (2015) Wing Lam et al. BMC Complementary and Alternative Medicine
- Old Drug New Use--Amoxapine and Its Metabolites as Potent Bacterial -Glucuronidase Inhibitors for Alleviating Cancer Drug Toxicity
- (2014) R. Kong et al. CLINICAL CANCER RESEARCH
- Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
- (2014) Nagendra Singh et al. IMMUNITY
- Intestinal microbiota: unexpected alliance with tumor therapy
- (2014) Naofumi Mukaida Immunotherapy
- The Role of Intestinal Microbiota in Development of Irinotecan Toxicity and in Toxicity Reduction through Dietary Fibres in Rats
- (2014) Xiaoxi B. Lin et al. PLoS One
- Immunological off-target effects of standard treatments in gastrointestinal cancers
- (2013) A. G. Duffy et al. ANNALS OF ONCOLOGY
- Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
- (2013) Aleksandar D. Kostic et al. Cell Host & Microbe
- A Shigella Effector Dampens Inflammation by Regulating Epithelial Release of Danger Signal ATP through Production of the Lipid Mediator PtdIns5P
- (2013) Andrea Puhar et al. IMMUNITY
- The role of p38 in irinotecan-induced DNA damage and apoptosis of colon cancer cells
- (2013) E. Rudolf et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Shigella impairs T lymphocyte dynamics in vivo
- (2013) W. Salgado-Pabon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics
- (2013) Josephine S. Kim et al. SUPPORTIVE CARE IN CANCER
- Interaction between Host Cells and Microbes in Chemotherapy-Induced Mucositis
- (2013) Andrea Stringer Nutrients
- The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response
- (2012) Takahito Sanada et al. NATURE
- Irinotecan (CPT-11) Chemotherapy Alters Intestinal Microbiota in Tumour Bearing Rats
- (2012) Xiaoxi B. Lin et al. PLoS One
- Comparative Analysis of Esterase Activities of Human, Mouse, and Rat Blood
- (2011) E. V. Rudakova et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- The Shigella flexneri Type Three Secretion System Effector IpgD Inhibits T Cell Migration by Manipulating Host Phosphoinositide Metabolism
- (2011) Christoph Konradt et al. Cell Host & Microbe
- Metabolic activities and probiotic potential of bifidobacteria
- (2011) D.A. Russell et al. INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY
- Treg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy
- (2011) Patricia López et al. VACCINE
- Faecal microflora and β-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats
- (2010) Andrea M Stringer et al. CANCER BIOLOGY & THERAPY
- Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen
- (2010) Akinobu Kurita et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Role of the gut microbiota in defining human health
- (2010) Kei E Fujimura et al. Expert Review of Anti-Infective Therapy
- Th17 Cells Are the Dominant T Cell Subtype Primed by Shigella flexneri Mediating Protective Immunity
- (2010) Gernot Sellge et al. JOURNAL OF IMMUNOLOGY
- The geometry of DNA supercoils modulates the DNA cleavage activity of human topoisomerase I
- (2010) A. C. Gentry et al. NUCLEIC ACIDS RESEARCH
- Effects of Mannose-Binding Lectin Polymorphisms on Irinotecan-Induced Febrile Neutropenia
- (2010) J. M. van der Bol et al. ONCOLOGIST
- Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
- (2010) B. D. Wallace et al. SCIENCE
- The Four-Herb Chinese Medicine PHY906 Reduces Chemotherapy-Induced Gastrointestinal Toxicity
- (2010) W. Lam et al. Science Translational Medicine
- Prophylactic ciprofloxacin treatment prevented high mortality and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy
- (2009) H Xue et al. BRITISH JOURNAL OF CANCER
- Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review
- (2009) Glenn E Palomaki et al. GENETICS IN MEDICINE
- Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer
- (2009) Cathy Eng Nature Reviews Clinical Oncology
- VirulentShigella flexnerisubverts the host innate immune response through manipulation of antimicrobial peptide gene expression
- (2008) Brice Sperandio et al. JOURNAL OF EXPERIMENTAL MEDICINE
- OspF directly attenuates the activity of extracellular signal-regulated kinase during invasion by Shigella flexneri in human dendritic cells
- (2008) Dong Wook Kim et al. MOLECULAR IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started